IGF-1 LR3 is listed as a nominal 1 mg vial. The LR3 designation is part of the compound identity. The original source document provides the identity statement and sample result shown below.
Compound
IGF-1 LR3
Nominal format
1 mg
Presentation
Research vial
Intended use
Laboratory research only
CAS, as reported
143045-27-6
Molecular weight, as reported
9117.5 g/mol
Availability
To be confirmed before launch
This is a product reference sheet, not a Certificate of Analysis.
Monarch Lab source report
Reported purity.
99.90%UHPLC with MS Source sample result
BioRegen analysis, published by Monarch Lab. Purity is reported for the source sample.
Source report
#13932
Source lot
Not stated
Date on source report
09/04/26
Format stated in report
1 mg
Measured amount
Not stated in report
Identity result
IGF-1 LR3
Source specification
>99% purity
Full analytical fields
Heavy metals
Not stated in report
Sterility
Not stated in report
Endotoxin
Not stated in report
Missing test results are not treated as passed tests.
For qualified laboratory research and educational evaluation only. Not for human, veterinary or food use. These materials are not intended to diagnose, treat, cure or prevent disease. Scientific references, where provided, offer research context; they are not medical advice or evidence of therapeutic suitability. Purchasers are responsible for qualified handling and compliance with applicable requirements.
Veelyon Lab notes
New compounds. New source reports.
Get Veelyon Lab catalog updates, newly published documents and occasional offers by email.